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In order to silence the expression levels of pathogenic genes, small interfering RNA (siRNA) requires a 
nano-sized carrier for its safe and stable delivery into cells. In this research highlight, we focus on well-defined 
cationic nanohydrogel particles developed in our group for such purposes. To investigate the nanogels’ 
mechanism for enhanced knockdown efficiencies, we recently synthesized two sets of particles with similar 
material composition and siRNA-loading characteristics, but – according to the manufacturing process – of 
different sizes. Within this study, 100-nm-sized nanogel particles loaded with siRNA accumulated inside the 
lysosomes already after 4 h and could not induce any gene knockdown, while 40-nm-sized particles were able to 
avoid lysosomal accumulation, and instead, generated moderate gene knockdown levels lasting for about three 
days. We believe that in analogy to other reports this size-dependent intracellular distribution behavior might be 
an essential key parameter for tuning the knockdown efficiency of the nanogel carriers. Moreover, these results 
might further contribute to the development of advanced siRNA carrier systems in order to enhance RNAi’s 
translation into the clinics. 
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Already very early after its discovery RNA intereference 
(RNAi) [1, 2] was considered as promising therapeutic 
alternative for the treatment of various pathogenic genes [3, 4]. 
However, due to its physicochemical properties small 
interfering RNA (siRNA) cannot be applied as a drug 
systemically: Besides rapid enzymatic degradation or renal 
clearance the negatively charged phosphodiester backbone 
prevents the double-stranded oligonucleotides from cellular 
uptake and release into the cytosol, where an enzymatic 
protein machinery can be recruited for sequence specific 
mRNA degradation [5].  
Influenced by the thriving research on nanomedicines,[6] 
several delivery approaches have been developed throughout 
the last decade progressing RNAi to be translated into the 
clinics [7]. Among various concepts proceeding in market or 
final development, nanohydrogel particles have gained more 
attraction recently [8]: They are pre-defined in size and shape 
but independent from their siRNA payload and can, thus, act 
as improved siRNA transporter with enhanced stability 
properties under physiological relevant conditions. 
For such purposes, our group developed a novel synthetic 
approach towards cationic nanohydrogel particles for siRNA 
delivery by combination of controlled radical polymerization 
of reactive precursor block copolymers, their spontaneous 
self-assembly into nano-sized micellar aggregates and 
subsequent core cross-linking to install cationic charges for 
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siRNA complexation [9]. The obtained nanogels do not 
change their morphology after loading with siRNA but 
facilitate their uptake into cells over time properly. 
Moreover, the nanoparticles’ stability under biologically 
relevant conditions could carefully be investigated by 
dynamic light scattering in human blood serum as well as by 
intravital video microscopy in the bloodstream of mice [10].  
More recently, we paid detailed attention to the 
nanohydrogel’s ability of mediating gene knockdown in an in 
vitro assay by its siRNA payload [11]: For that purpose two 
sets of well-defined cationic nanohydrogel particles were 
generated that – according to the manufacturing protocol – 
provided nanogels of similar material composition, yet, a 
difference in size was obtained by introducing precursor 
block copolymers of same block ratio but different molecular 
weight. Consequently, particles with diameters of about 
40 nm and 100 nm were generated, which provided similar 
siRNA loading as well as release capabilites. Interestingly, 
no difference in cell viability was monitored when they were 
applied to luciferase-expressing HeLa cells at different 
nanogel concentrations (loaded either with or without siRNA 
targeted against luciferase as model gene). However, 
different results were found for the luciferase expression 
levels by measuring the cells’ relative luminescence. Only 
the 40-nm-sized nanohydrogel particles seemed to induce a 
siRNA-mediated moderate gene knockdown (Figure 1), 
while for the 100-nm sized nanohydrogel particles no 
difference in luciferase activity was found (Figure 2). This 
knockdown potential could be verified by real time 
luminescence monitoring for the 40-nm-sized particles, too. 
A significant gene knockdown of could be detected 
compared to control nanogel particles loaded with scramble 
siRNA [11]. Although the knockdown efficiencies were 
moderate, they seemed to be quite stable and continuing over 
time only for the small-sized particles.  
To explain the exclusive knockdown potential for cationic 
nanohydrogel particles of similar composition but different 
size, cell uptake and lysosomal colocalization studies were 
performed in HeLa cells over time, too. Thereby, we 
observed that both particles provided similar uptake 
Figure 1. SiRNA-loaded cationic nanohydrogel particles with diameters of about 40 nm can avoid accumulation inside lysosomes 
but induce siRNA-mediated gene knockdown. Left: Schematic mechanism. Middle: Confocal image of HeLa cells (cell membranes in 
blue and lysosomes in red) incubated with cationic nanohydrogel particles (green) – scale bar = 25 µm. Right: Endogenous luciferase gene 
silencing in HeLa-Luc cells after incubation for 48 h with 400 nM siRNA. Adapted with permission from reference [11]. Copyright 2014, 
American Chemical Society. 
 
Figure 2. SiRNA-loaded cationic nanohydrogel particles with diameters of about 100 nm accumulate inside lysosomes and, thus, 
cannot induce siRNA-mediated gene knockdown. Left: Schematic mechanism. Middle: Confocal image of HeLa cells (cell membranes in 
blue and lysosomes in red) incubated with cationic nanohydrogel particles (green) – scale bar = 25 µm. Right: Endogenious luciferase gene 
silencing in HeLa-Luc cells after incubation for 48 h with 400 nM siRNA. Adapted with permission from reference [11]. Copyright 2014, 
American Chemical Society. 
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efficiencies, yet, their intracellular distribution differed again 
significantly. While the 100-nm-sized particles accumulated 
inside lysosomes already after 4h (Figure 2), most of the 
40-nm-sized particles seemed to avoid these compartments 
even after incubation for 24h (Figure 1) [11]. In conclusion, 
the nanohydrogel particles’ knockdown efficiency can 
directly be correlated to less lysosomal colocalization. In that 
context, the nanogels’ size already seems to be an essential 
key parameter for affecting their intracellular trafficking and 
distribution.  
Avoiding cellular uptake pathways that are subsequently 
directed to lysosomal compartments, where oligonucleotides 
can be degraded rapidly, are generally considered to be one 
of the major bottlenecks in siRNA delivery. Moreover, by 
methods to retain siRNA inside endosomal compartments 
Sahay et al. could recently enhance the gene silencing 
potential effectively [12, 13]. Consequently, increased siRNA 
residence time in non-lysosomal compartments might 
contribute to a slow, controlled diffusion of the 
oligonucleotide from such reservoirs into the cytosol, 
followed by robust gene knockdown. We assume that the 
small-sized cationic nanohydrogel particles presented in our 
last study [11] might have found access to an cellular uptake 
pathway that avoids lysosomal accumulation. Among several 
endocytotic uptake mechanisms some are well-known to 
avoid vesicle fusion with lysosomes (e.g. caveolin-mediated 
endocytosis [14]). As a result, the internalized particles can be 
stored in non-acidic, non-degrading cellular compartments, 
where the carriers act as reservoirs for slow, long-lasting 
release of their payload. So far, the nanohydrogel particles do 
not provide any membrane-disruptive elements, which might 
increase their penetration into the cytosol for better access to 
the RNAi-machinery. This, however, might on the other 
hand also induce decreased cell viability, which could not be 
found so far for the nanogel carriers at the current stage. The 
moderate silencing efficiencies observed for the 40-nm-sized 
nanogel carriers are probably due to their high 
siRNA-complex stabilities under physiological relevant 
conditions [10]. To that respect, we are currently focusing on 
advanced cationic nanohydrogel systems with 
stimuli-responsive groups that allow side-specific carrier 
degradation as well as efficient siRNA release. As an 
example, we recently introduced novel reductive-degradable 
cationic nanohydrogel particles that showed both 
redox-triggered particle degradation into its polymer 
fragments as well as release of complexed siRNA payload 
under reductive conditions of the cytosol [15].  
In analogy to previously reported studies, we assume that 
the size-dependent knockdown efficiency, which we found in 
our study for the 40-nm-sized cationic nanohydrogel 
particles compared to the 100-nm-sized carriers exclusively 
[11], might open possibilities to improve the knockdown 
potential of other siRNA delivery systems, too, by simply 
addressing subcellular uptake pathways that avoid lysosomal 
accumulation. This might perhaps already be accessible for 
carrier systems of smaller sizes (e.g. around 40 nm). To that 
respect, we believe that our observations could also 
contribute to the development of further advanced siRNA 
carrier systems, which may enhance RNAi’s translation into 
the clinics. 
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